CurrentBlue Cross Blue Shield - MassachusettsPolicy 126

Catheter Ablation for Cardiac Arrhythmias

Defines medical necessity and investigational indications for catheter ablation of supraventricular and ventricular arrhythmias for Blue Cross Blue Shield Massachusetts members; covers authorization expectations and coding guidance for inpatient and outpatient settings.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyCatheter Ablation for Cardiac Arrhythmias

Policy CodePolicy 126

Change TypeNo material changes

Effective Date

Next Review Date

Key ActionObtain precertification/preauthorization for inpatient catheter ablation procedures for all products.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

≈90%procedural success

80–90%VT procedural success

≈1%AV block risk

1.3%stroke/TIA

2%vascular injury

51+

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Catheter Ablation

inv-01: Medically Necessary Indications

Covered when ALL of the following are met for specified indications

Supraventricular tachyarrhythmias - indications

WPW additional conditions: Member is asymptomatic AND assessed to be at high risk of life-threatening arrhythmias determined by persistence of delta wave during an exercise tolerance test achieving maximal heart rate.

Ventricular tachycardia - refractory disease

VT storm (≥3 sustained VT episodes in 24 hours) that has failed pharmacologic therapy may be treated with catheter ablation.

First-line for supraventricular arrhythmias: Catheter ablation may be considered first-line for the supraventricular tachyarrhythmias listed; prior failure of medical therapy is not required.

inv-02: Investigational / Not Medically Necessary

Not covered indications

Other ventricular arrhythmias: Catheter ablation for all other ventricular arrhythmias is considered investigational (not medically necessary).

Catheter ablation for ventricular arrhythmias is limited to specific, evidence-supported situations. Catheter ablation using radiofrequency energy may be considered medically necessary for chronic, recurrent ventricular tachycardia that is refractory to implantable cardioverter defibrillator (ICD) therapy and antiarrhythmic medications when an identifiable arrhythmogenic focus can be located. Additionally, ablation for ventricular tachycardia (VT) storm—defined in policy guidance as ≥3 sustained VT episodes in 24 hours—may be considered medically necessary when pharmacologic therapy has failed to control the arrhythmia.

Catheter ablation for ventricular arrhythmias outside the indications listed above is considered investigational and therefore not medically necessary. The policy explicitly states that catheter ablation for all other ventricular arrhythmias is considered investigational.

Coding and Billing Guidance

Covered CPT CodesCPTCovered

93653	Comprehensive electrophysiologic evaluation with intracardiac catheter ablation; treatment of supraventricular tachycardia (ablation of AV pathway, accessory connection, cavo-tricuspid isthmus or other single atrial focus).
93654	Comprehensive electrophysiologic evaluation with intracardiac catheter ablation; treatment of ventricular tachycardia or focus of ventricular ectopy, including 3D mapping when performed.
93655	Intracardiac catheter ablation of a discrete mechanism distinct from the primary ablated mechanism (add-on code).

Relevant ICD-10 Diagnosis CodesICD-10

I45.6	Pre-excitation syndrome.
I47.0	Re-entry ventricular arrhythmia.
I47.10	Supraventricular tachycardia, unspecified.
I47.11	Inappropriate sinus tachycardia, so stated.
I47.19	Other supraventricular tachycardia.
I47.20	Ventricular tachycardia, unspecified.
I47.21	Torsades de pointes.
I47.29	Other ventricular tachycardia.
I47.9	Paroxysmal tachycardia, unspecified.
I48.3	Typical atrial flutter.

1–10 of 15

1/2

Provider Actions and Authorization

Prior Authorization

Prior Authorization Required

For services described in this policy, precertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient.

Precertification/preauthorization is required for ALL products when catheter ablation is performed in an inpatient setting.

Prior Authorization

Outpatient Prior Authorization Not Required for Specified Products

For the outpatient setting, prior authorization is not required for the products listed below.

Commercial Managed Care (HMO and POS), Outpatient = Prior authorization is not required.
Commercial PPO and Indemnity, Outpatient = Prior authorization is not required.
Medicare HMO Blue SM, Outpatient = Prior authorization is not required.
Medicare PPO Blue SM, Outpatient = Prior authorization is not required.

Background and Clinical Context

Catheter ablation is a percutaneous electrophysiologic procedure that targets cardiac tissue responsible for arrhythmias. The procedure typically uses energy sources such as radiofrequency energy to create focal lesions that eliminate or isolate abnormal conduction pathways or ectopic foci. Preprocedural localization methods, including electroanatomic mapping, are used to identify the arrhythmogenic focus or culprit pathway prior to delivering ablation energy.

Definitions

Ventricular tachycardia storm

DefinitionVentricular tachycardia storm (incessant ventricular tachycardia): at least 3 episodes of sustained ventricular tachycardia in a 24-hour period.

Clinical significanceConsidered life‑threatening and requires prompt attention and treatment.

SynonymAlso referred to as incessant ventricular tachycardia.

Implication for therapyMay be considered medically necessary for catheter ablation when pharmacologic treatment has failed.